Company Description
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally.
The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables.
The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications.
In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software.
Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Jul 15, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 171 |
| CEO | Robert Spignesi |
Contact Details
Address: 25 Hartwell Avenue Lexington, Massachusetts 02421 United States | |
| Phone | 978 349 3200 |
| Website | rapidmicrobio.com |
Stock Details
| Ticker Symbol | RPID |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $20.00 |
| CIK Code | 1380106 |
| CUSIP Number | 75340L104 |
| ISIN Number | US75340L1044 |
| Employer ID | 20-8121647 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Sean M. Wirtjes CPA | Chief Financial Officer |
| Michael Beaulieu C.F.A. | Vice President of Investor Relations and Corporate Communications |
| James Xu | Senior Vice President of Legal and Secretary |
| Katherine Atkinson | Senior Vice President of Global Sales and Marketing |
| Julie Jarvie | Senior Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2026 | ARS | Filing |
| Apr 8, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2026 | 8-K | Current Report |
| Mar 12, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 12, 2026 | 10-K | Annual Report |
| Mar 12, 2026 | 8-K | Current Report |
| Mar 11, 2026 | 144 | Filing |
| Mar 11, 2026 | 144 | Filing |
| Mar 10, 2026 | 144 | Filing |